{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:00:34Z","timestamp":1761919234405},"reference-count":28,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2008,12,11]],"date-time":"2008-12-11T00:00:00Z","timestamp":1228953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2009,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background: <\/jats:bold> Genotype 2\/3 hepatitis C virus (HCV) has a good response to treatment with peginterferon and ribavirin. Patients with psychiatric disorders and injecting drug users (IDUs) are considered \u2018difficult to treat\u2019 and are often excluded from treatment despite the lack of evidence supporting this decision.<\/jats:p><jats:p><jats:bold>Aims: <\/jats:bold> To investigate the outcome and factors associated with treatment failure in these groups.<\/jats:p><jats:p><jats:bold>Methods: <\/jats:bold> This is an observational study of a cohort of patients infected by genotype 2\/3 HCV. IDUs and patients with psychiatric diseases were not excluded from treatment. We performed an intention\u2010to\u2010treat analysis to evaluate factors related to treatment failure.<\/jats:p><jats:p><jats:bold>Results: <\/jats:bold> A sustained virological response (SVR) was achieved in 91 of the 125 patients treated (72.8%). Patients with chronic psychotic disorders or former IDUs had SVR rates similar to other groups. After multivariate analysis, independent factors associated with treatment failure were liver cirrhosis [odds ratio (OR) 3.4, 95% confidence interval (CI) 1.1\u201310.4], a history of depression and not being on antidepressants at the commencement of HCV treatment (OR 4.4, 95% CI 1.2\u201316) and active IDUs (OR 7.3, 95% CI 1.77\u201330.4).<\/jats:p><jats:p><jats:bold>Conclusions: <\/jats:bold> Patients with a history of depression who were not receiving antidepressants and active IDUs are more likely to fail treatment for genotype 2\/3 HCV and will need additional support.<\/jats:p>","DOI":"10.1111\/j.1478-3231.2008.01958.x","type":"journal-article","created":{"date-parts":[[2009,7,2]],"date-time":"2009-07-02T08:19:46Z","timestamp":1246522786000},"page":"1051-1055","source":"Crossref","is-referenced-by-count":31,"title":["Factors associated with treatment failure of patients with psychiatric diseases and injecting drug users in the treatment of genotype 2 or 3 hepatitis C chronic infection"],"prefix":"10.1111","volume":"29","author":[{"given":"Gerardo","family":"Alvarez\u2010Uria","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy N.","family":"Day","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anisa J.","family":"Nasir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan K.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco Javier","family":"Vilar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,7,2]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20119"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2007.08.014"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05800.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2007.04.004"},{"key":"e_1_2_6_6_2","first-page":"315","article-title":"Hepatitis C in psychiatry inpatients","volume":"15","author":"Lacey C","year":"2007","journal-title":"testing rates, prevalence and risk behaviours"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.41860.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-136-4-200202190-00008"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/94.3.153"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1086\/427448"},{"key":"e_1_2_6_11_2","first-page":"41","article-title":"Depression during pegylated interferon\u2010alpha plus ribavirin therapy","volume":"66","author":"Raison CL","year":"2005","journal-title":"prevalence and prediction"},{"key":"e_1_2_6_12_2","first-page":"531","article-title":"Therapy of interferon\u2010induced depression in chronic hepatitis C with citalopram","volume":"57","author":"Kraus MR","year":"2008","journal-title":"a randomised, double-blind, placebo-controlled study"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-006-9729-5"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03316.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.01.020"},{"key":"e_1_2_6_16_2","first-page":"991","article-title":"Hepatitis C treatment in \u201cdifficult\u2010to\u2010treat\u201d psychiatric patients with pegylated interferon\u2010alpha and ribavirin","volume":"46","author":"Schaefer M","year":"2007","journal-title":"response and psychiatric side effects"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-9338(01)00553-3"},{"key":"e_1_2_6_18_2","first-page":"406","article-title":"Psychosis during peginterferon\u2010alpha2a and ribavirin therapy","volume":"10","author":"Quarantini LC","year":"2006","journal-title":"case report"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.yic.0000170263.46008.54"},{"key":"e_1_2_6_20_2","first-page":"446","article-title":"Persistent psychosis after treatment with interferon alpha","volume":"26","author":"Telio D","year":"2006","journal-title":"a case report"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-9338(03)00032-4"},{"key":"e_1_2_6_22_2","first-page":"655","article-title":"Psychiatric symptoms induced by antiviral therapy in chronic hepatitis C","volume":"26","author":"Neri S","year":"2006","journal-title":"comparison between interferon-alpha-2a and interferon-alpha-2b"},{"key":"e_1_2_6_23_2","first-page":"165","article-title":"Interferon\u2010alpha can be used successfully in patients with hepatitis C virus\u2010positive chronic hepatitis who have a psychiatric illness","volume":"7","author":"Van Thiel DH","year":"1995","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01425.x"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20279"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200602000-00008"},{"key":"e_1_2_6_27_2","first-page":"199","article-title":"Hepatitis C treatment candidacy and outcomes among 4318 US veterans with chronic hepatitis C virus infection","volume":"41","author":"Seal KH","year":"2007","journal-title":"does a history of injection drug use matter?"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1086\/427449"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2007.01.009"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1478-3231.2008.01958.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1478-3231.2008.01958.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T18:39:03Z","timestamp":1697135943000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1478-3231.2008.01958.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,2]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["10.1111\/j.1478-3231.2008.01958.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1478-3231.2008.01958.x","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,2]]}}}